Journal of Clinical Oncology

Reply to: Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas

C Christopher L. Moertel (Christopher L. Moertel, MD, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Angela C. Hirbe, MD, PhD, Washington University School of Medicine in St Louis, St Louis, MO; Laura J. Klesse, MD, PhD, University of Texas Southwestern/Children's Health, Dallas, TX; P. Leia Nghiemphu, MD, University of California Los Angeles (UCLA), Los Angeles, CA; Dusica Babovic-Vuksanovic, MD, Mayo Clinic, Rochester, MN; and Timothy R. Gershon, MD, PhD, Department of Pediatrics, Emory University, Atlanta, GA) A Angela C. Hirbe (Christopher L. Moertel, MD, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Angela C. Hirbe, MD, PhD, Washington University School of Medicine in St Louis, St Louis, MO; Laura J. Klesse, MD, PhD, University of Texas Southwestern/Children's Health, Dallas, TX; P. Leia Nghiemphu, MD, University of California Los Angeles (UCLA), Los Angeles, CA; Dusica Babovic-Vuksanovic, MD, Mayo Clinic, Rochester, MN; and Timothy R. Gershon, MD, PhD, Department of Pediatrics, Emory University, Atlanta, GA) L Laura J. Klesse P P. Leia Nghiemphu (Christopher L. Moertel, MD, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Angela C. Hirbe, MD, PhD, Washington University School of Medicine in St Louis, St Louis, MO; Laura J. Klesse, MD, PhD, University of Texas Southwestern/Children's Health, Dallas, TX; P. Leia Nghiemphu, MD, University of California Los Angeles (UCLA), Los Angeles, CA; Dusica Babovic-Vuksanovic, MD, Mayo Clinic, Rochester, MN; and Timothy R. Gershon, MD, PhD, Department of Pediatrics, Emory University, Atlanta, GA) D Dusica Babovic-Vuksanovic (Christopher L. Moertel, MD, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Angela C. Hirbe, MD, PhD, Washington University School of Medicine in St Louis, St Louis, MO; Laura J. Klesse, MD, PhD, University of Texas Southwestern/Children's Health, Dallas, TX; P. Leia Nghiemphu, MD, University of California Los Angeles (UCLA), Los Angeles, CA; Dusica Babovic-Vuksanovic, MD, Mayo Clinic, Rochester, MN; and Timothy R. Gershon, MD, PhD, Department of Pediatrics, Emory University, Atlanta, GA) T Timothy R. Gershon
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 15
Published May 20, 2025
Pages 1844-1846
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (6)

C

Christopher L. Moertel

Christopher L. Moertel, MD, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Angela C. Hirbe, MD, PhD, Washington University School of Medicine in St Louis, St Louis, MO; Laura J. Klesse, MD, PhD, University of Texas Southwestern/Children's Health, Dallas, TX; P. Leia Nghiemphu, MD, University of California Los Angeles (UCLA), Los Angeles, CA; Dusica Babovic-Vuksanovic, MD, Mayo Clinic, Rochester, MN; and Timothy R. Gershon, MD, PhD, Department of Pediatrics, Emory University, Atlanta, GA

A

Angela C. Hirbe

Christopher L. Moertel, MD, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Angela C. Hirbe, MD, PhD, Washington University School of Medicine in St Louis, St Louis, MO; Laura J. Klesse, MD, PhD, University of Texas Southwestern/Children's Health, Dallas, TX; P. Leia Nghiemphu, MD, University of California Los Angeles (UCLA), Los Angeles, CA; Dusica Babovic-Vuksanovic, MD, Mayo Clinic, Rochester, MN; and Timothy R. Gershon, MD, PhD, Department of Pediatrics, Emory University, Atlanta, GA

L

Laura J. Klesse

P

P. Leia Nghiemphu

Christopher L. Moertel, MD, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Angela C. Hirbe, MD, PhD, Washington University School of Medicine in St Louis, St Louis, MO; Laura J. Klesse, MD, PhD, University of Texas Southwestern/Children's Health, Dallas, TX; P. Leia Nghiemphu, MD, University of California Los Angeles (UCLA), Los Angeles, CA; Dusica Babovic-Vuksanovic, MD, Mayo Clinic, Rochester, MN; and Timothy R. Gershon, MD, PhD, Department of Pediatrics, Emory University, Atlanta, GA

D

Dusica Babovic-Vuksanovic

Christopher L. Moertel, MD, Department of Pediatrics, University of Minnesota, Minneapolis, MN; Angela C. Hirbe, MD, PhD, Washington University School of Medicine in St Louis, St Louis, MO; Laura J. Klesse, MD, PhD, University of Texas Southwestern/Children's Health, Dallas, TX; P. Leia Nghiemphu, MD, University of California Los Angeles (UCLA), Los Angeles, CA; Dusica Babovic-Vuksanovic, MD, Mayo Clinic, Rochester, MN; and Timothy R. Gershon, MD, PhD, Department of Pediatrics, Emory University, Atlanta, GA

T

Timothy R. Gershon

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001